These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 8826810)

  • 21. The UNOS Scientific Renal Transplant Registry--ten years of kidney transplants.
    Cecka JM
    Clin Transpl; 1997; ():1-14. PubMed ID: 9919387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of antibody induction on transplant outcomes in human leukocyte antigen zero-mismatch deceased donor kidney recipients.
    Kuo HT; Huang E; Emami S; Pham PT; Wilkinson AH; Danovitch GM; Bunnapradist S
    Transplantation; 2012 Mar; 93(5):493-502. PubMed ID: 22306574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multivariate analysis of the effectiveness of using antibody induction therapy according to the degree of HLA mismatches.
    Bunnapradist S; Hong A; Lee B; Takemoto SK
    Transplant Proc; 2005 Mar; 37(2):886-8. PubMed ID: 15848565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transplantation results of completely HLA-mismatched living and completely HLA-matched deceased-donor kidneys are comparable.
    Laging M; Kal-van Gestel JA; Haasnoot GW; Claas FH; van de Wetering J; Ijzermans JN; Weimar W; Roodnat JI
    Transplantation; 2014 Feb; 97(3):330-6. PubMed ID: 24202143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A multi-factor analysis of kidney regraft outcomes.
    Gjertson DW
    Clin Transpl; 2002; ():335-49. PubMed ID: 12971460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using the mimetic epitope concept to find a possible way to widen the graft-survival difference between matched and mismatched renal transplants.
    Sasaki N; Idica A; Hall B; Terasaki PI
    Clin Transpl; 2008; ():241-52. PubMed ID: 19711515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Refinement of permissible HLA mismatches.
    Takemoto S; Terasaki PI
    Clin Transpl; 1994; ():451-66. PubMed ID: 7547575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of HLA mismatch on rejection after heart transplantation: a multiinstitutional study. The Cardiac Transplant Research Database Group.
    Jarcho J; Naftel DC; Shroyer TW; Kirklin JK; Bourge RC; Barr ML; Pitts DG; Starling RC
    J Heart Lung Transplant; 1994; 13(4):583-95; discussion 595-6. PubMed ID: 7947874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. KIR and their HLA Class I ligands: Two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantation.
    Littera R; Piredda G; Argiolas D; Lai S; Congeddu E; Ragatzu P; Melis M; Carta E; Michittu MB; Valentini D; Cappai L; Porcella R; Alba F; Serra M; Loi V; Maddi R; Orrù S; La Nasa G; Caocci G; Cusano R; Arras M; Frongia M; Pani A; Carcassi C
    PLoS One; 2017; 12(7):e0180831. PubMed ID: 28686681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term impact of human leukocyte antigen mismatches combined with expanded criteria donor on allograft outcomes in deceased donor kidney transplantation.
    Shin S; Kim YH; Choi BH; Choi JY; Jung JH; Cho HK; Han DJ
    Clin Transplant; 2015 Jan; 29(1):44-51. PubMed ID: 25382387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
    Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
    J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence that HLA class II disparity is required for the induction of renal allograft enhancement by donor-specific blood transfusions in man.
    Lazda VA; Pollak R; Mozes MF; Barber PL; Jonasson O
    Transplantation; 1990 Jun; 49(6):1084-7. PubMed ID: 2360251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of Human Leukocyte Antigen Compatibility in Graft Outcomes After Living Donor Liver Transplantation.
    Shin M; Kim JM; Kwon CH; Kim SJ; Joh JW
    Transplant Proc; 2016 May; 48(4):1123-9. PubMed ID: 27320571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kidney transplantation in the US: an analysis of the OPTN/UNOS registry.
    Freitas MC
    Clin Transpl; 2011; ():1-16. PubMed ID: 22755397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Donor catecholamine use reduces acute allograft rejection and improves graft survival after cadaveric renal transplantation.
    Schnuelle P; Lorenz D; Mueller A; Trede M; Van Der Woude FJ
    Kidney Int; 1999 Aug; 56(2):738-46. PubMed ID: 10432416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibodies against MICA antigens and kidney-transplant rejection.
    Zou Y; Stastny P; Süsal C; Döhler B; Opelz G
    N Engl J Med; 2007 Sep; 357(13):1293-300. PubMed ID: 17898098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA-DQ matching in cadaveric renal transplantation.
    Freedman BI; Thacker LR; Heise ER; Adams PL
    Clin Transplant; 1997 Oct; 11(5 Pt 2):480-4. PubMed ID: 9361945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The UNOS Scientific Renal Transplant Registry.
    Cecka JM
    Clin Transpl; 1999; ():1-21. PubMed ID: 11038622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of HLA-DQ Matching on Allograft Outcomes in Deceased Donor Kidney Transplantation.
    Khongjaroensakun N; Kitpoka P; Wiwattanathum P; Sakulchairungrueng B; Thammanichanond D
    Transplant Proc; 2018 Oct; 50(8):2371-2376. PubMed ID: 30316360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Six-antigen-matched transplants. Causes of failure.
    Takemoto S; Cecka JM; Gjertson DW; Terasaki PI
    Transplantation; 1993 May; 55(5):1005-8. PubMed ID: 8497872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.